⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for chk1 inhibitor

Every month we try and update this database with for chk1 inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced CancersNCT02514603
Neoplasm
Prexasertib
20 Years - Eli Lilly and Company
A Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerNCT02797964
Advanced Solid ...
SRA737
18 Years - Sierra Oncology LLC - a GSK company
A Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerNCT02797964
Advanced Solid ...
SRA737
18 Years - Sierra Oncology LLC - a GSK company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: